Advertisement
Singapore markets close in 47 minutes
  • Straits Times Index

    3,301.06
    -2.13 (-0.06%)
     
  • Nikkei

    38,835.10
    +599.03 (+1.57%)
     
  • Hang Seng

    18,469.18
    -109.12 (-0.59%)
     
  • FTSE 100

    8,281.58
    +68.09 (+0.83%)
     
  • Bitcoin USD

    63,658.42
    -912.89 (-1.41%)
     
  • CMC Crypto 200

    1,369.45
    +4.32 (+0.32%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • Dow

    38,852.27
    +176.59 (+0.46%)
     
  • Nasdaq

    16,349.25
    +192.92 (+1.19%)
     
  • Gold

    2,327.80
    -3.40 (-0.15%)
     
  • Crude Oil

    78.55
    +0.07 (+0.09%)
     
  • 10-Yr Bond

    4.4890
    -0.0110 (-0.24%)
     
  • FTSE Bursa Malaysia

    1,606.83
    +9.44 (+0.59%)
     
  • Jakarta Composite Index

    7,141.79
    +5.90 (+0.08%)
     
  • PSE Index

    6,618.58
    -33.91 (-0.51%)
     

Lannett Company, inc (LCI) Q1 2022 Earnings Call Transcript

Lannett Company, inc (LCI) Q1 2022 Earnings Call Transcript

Good afternoon, everyone, and thank you for joining us today to discuss Lannett Company's fiscal 2022 first quarter financial results. On the call today are Tim Crew, Chief Executive Officer; John Kozlowski, the company's Chief Financial Officer; Maureen Cavanaugh, our Chief Commercial Operations Officer; and Steve Lehrer, who leads our biosimilar insulin initiatives.